Tilch MK, Galle PR, Schattenberg JM, Kostev K, Labenz C. Burden of depression and anxiety disorders per disease codes in patients with lymphoma in Germany. Support Care Cancer. 2022 Mar;30(3):2387-2395. doi: 10.1007/s00520-021-06677-w. Epub 2021 Nov 10. PMID: 34761297; PMCID: PMC8795002.

Tilch MK, Robak T, Ghiggi C, Wuff E, Herold S, Theobald M, Hess G. Safety of the Anti-CD19 antibody Tafasitamab in Long Term Responders from A Phase II Trial for Relapsed Lymphoma. Clin Lymphoma Myeloma Leuk. 2021 Oct 16:S2152-2650(21)02382-X. doi: 10.1016/j.clml.2021.10.005. Epub ahead of print. PMID: 34776401.

Schwaegermann MK, Hobohm L, Rausch J, Reuter M, Griemert TF, Sivanathan V, Falter T, Sprinzl MF, Lackner KJ, Galle PR, Konstantinides S, Theobald M, von Auer C. COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case Report. Hamostaseologie. 2021 Jul 29. doi: 10.1055/a-1497-1054. Epub ahead of print. PMID: 34327693.

Schwaegermann MK, Schranz M, Moehler M, Labenz C, Moringlane A, Schmidt M, Theobald M, Hess G. Any progress in informed consenting for cancer treatment? Results from a cross sectional analysis at a comprehensive cancer center. J Cancer Res Clin Oncol. 2021 Jan 9. doi: 10.1007/s00432-020-03495-1. Epub ahead of print. PMID: 33420813.